New patent for Gilead Sciences drug EPCLUSA

August 28, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for EPCLUSA Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are twenty-six…

The post New patent for Gilead Sciences drug EPCLUSA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.